ctrl K

Watchlist Price Alert

Aardvark Therapeutics Inc... (AARD)

NASDAQ: AARD · Real-Time Price · USD

13.99

0.47 (3.51%)

At close: Jul 01, 2025, 9:59 AM

Aardvark Therapeutics Common Stock Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a
Operating Income	-22.79M	-7.42M	-11.36M
Interest Income	2.41M	1.42M	120K
Pretax Income	-20.59M	-7.21M	-13.56M
Net Income	-20.59M	-7.21M	-13.56M
Selling & General & Admin	5.3M	2.17M	2.7M
Research & Development	17.36M	4.48M	7.17M
Other Expenses	117K	762K	1.49M
Operating Expenses	22.79M	7.42M	11.36M
Interest Expense	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a
Cost & Expenses	22.79M	7.42M	11.36M
Income Tax Expense	n/a	n/a	n/a
Shares Outstanding (Basic)	12.91M	12.91M	9.73M
Shares Outstanding (Diluted)	12.91M	12.91M	9.73M
EPS (Basic)	-1.59	-0.56	-1.39
EPS (Diluted)	-1.59	-0.56	-1.39
EBITDA	-22.79M	-7.32M	-10.25M
EBIT	-22.67M	-7.42M	-10.36M
Depreciation & Amortization	16K	97K	110K